标题
Precision medicine: from pharmacogenomics to pharmacoproteomics
作者
关键词
Pharmacogenomics, Proteomics, Biomarker, Precision medicine
出版物
Clinical Proteomics
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-26
DOI
10.1186/s12014-016-9127-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- DNA Methylation of ADME Genes
- (2016) P Fisel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
- (2016) Desirée Hao et al. Metabolomics
- Pharmacometabolomics informs pharmacogenomics
- (2016) Drew Neavin et al. Metabolomics
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
- (2016) Gianmaria Miolo et al. Oncotarget
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical Measurements
- (2015) C. R. Ferreira et al. CLINICAL CHEMISTRY
- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
- (2015) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The second coming of epigenetic drugs: A more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression
- (2015) P. Hunter EMBO REPORTS
- Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma
- (2015) Rebecca L. Goldstein et al. JOURNAL OF CLINICAL INVESTIGATION
- FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing
- (2015) Kenneth D. Levy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro human cell line models to predict clinical response to anticancer drugs
- (2015) Nifang Niu et al. PHARMACOGENOMICS
- Genome-wide association studies in pharmacogenomics of antidepressants
- (2015) Eugene Lin et al. PHARMACOGENOMICS
- Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy
- (2015) S Cao et al. PHARMACOGENOMICS JOURNAL
- Senate panel approves $2 billion raise for NIH in 2016
- (2015) Jocelyn Kaiser SCIENCE
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Current Developments in Activity-Based Protein Profiling
- (2014) Lianne I. Willems et al. BIOCONJUGATE CHEMISTRY
- Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens
- (2014) DaRue A Prieto et al. Biomarkers in Medicine
- Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
- (2014) Yuan Ji et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quantitative targeted proteomics for understanding the blood–brain barrier: towards pharmacoproteomics
- (2014) Sumio Ohtsuki et al. Expert Review of Proteomics
- Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes
- (2014) Iakes Ezkurdia et al. HUMAN MOLECULAR GENETICS
- Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to theUGT1A1Genotype of Patients With Cancer
- (2014) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation and personalized medicine
- (2014) J. Tang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810
- (2014) Mara Colzani et al. MOLECULAR & CELLULAR PROTEOMICS
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Pharmaco-proteomics opportunities for individualizing neurovascular treatment
- (2014) M M Ning et al. NEUROLOGICAL RESEARCH
- Pharmacogenomic biomarkers in drug labels: what do they tell us?
- (2014) Richard Tutton PHARMACOGENOMICS
- Proteomics in mechanistic toxicology: History, concepts, achievements, caveats, and potential
- (2014) Thierry Rabilloud et al. PROTEOMICS
- Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
- (2014) N. Wagle et al. Cancer Discovery
- Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
- (2013) Hiltrud Brauch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
- (2013) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integrated Analysis of Transcriptomic and Proteomic Data
- (2013) Saad Haider et al. CURRENT GENOMICS
- Pharmacogenomics of lipid-lowering therapies
- (2013) Miao Hu et al. PHARMACOGENOMICS
- Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
- (2013) H. L. McLeod SCIENCE
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- How Chemoproteomics Can Enable Drug Discovery and Development
- (2012) Raymond E. Moellering et al. CHEMISTRY & BIOLOGY
- FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY
- (2012) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer
- (2012) Martin Klammer et al. MOLECULAR & CELLULAR PROTEOMICS
- Cancer pharmacogenomics: strategies and challenges
- (2012) Heather E. Wheeler et al. NATURE REVIEWS GENETICS
- Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
- (2012) C Fernandez-Rozadilla et al. PHARMACOGENOMICS JOURNAL
- Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity
- (2012) Anke Van Summeren et al. TOXICOLOGY IN VITRO
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Deep proteome and transcriptome mapping of a human cancer cell line
- (2011) N. Nagaraj et al. Molecular Systems Biology
- The quantitative proteome of a human cell line
- (2011) M. Beck et al. Molecular Systems Biology
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation
- (2011) Heather E Wheeler et al. PHARMACOGENOMICS
- Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line
- (2010) Christine Vogel et al. Molecular Systems Biology
- Genome-wide association studies in pharmacogenomics
- (2010) Alison A. Motsinger-Reif et al. Pharmacogenetics and Genomics
- Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry
- (2009) David L. Tabb et al. JOURNAL OF PROTEOME RESEARCH
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- Pharmacogenomic Discovery Using Cell-Based Models
- (2009) M. Welsh et al. PHARMACOLOGICAL REVIEWS
- Identifying the proteins to which small-molecule probes and drugs bind in cells
- (2009) S.-E. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
- (2008) J. C. Marioni et al. GENOME RESEARCH
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P450 and Chemical Toxicology
- (2007) F. Peter Guengerich CHEMICAL RESEARCH IN TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation